Generali: Crédit Suisse raises target price
(CercleFinance.com) - Following the publication of Generali's nine-month results, which, in the end, were better than expected, Crédit Suisse has decided to raise its EPS estimate by 4% for 2020, followed by 1% to 3.
5% for 2021-2025.
The analyst expects growth in operating profit and a better outlook for profitability for its non-life insurance business.
As a result, Crédit Suisse is raising its target price for the share from 12.5 euros to 14 euros (current price about 14.2 euros, +1%), although reiterates its underperform rating on the stock, believing that others have more attractive risk/return ratios.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
5% for 2021-2025.
The analyst expects growth in operating profit and a better outlook for profitability for its non-life insurance business.
As a result, Crédit Suisse is raising its target price for the share from 12.5 euros to 14 euros (current price about 14.2 euros, +1%), although reiterates its underperform rating on the stock, believing that others have more attractive risk/return ratios.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.